Literature DB >> 14630225

Recent advances in the use of neurotropic viruses for circuit analysis.

Lynn W Enquist1, J Patrick Card.   

Abstract

In the past decade, the literature describing how viruses can be used to define the synaptic architecture of the brain has increased dramatically. Early studies focused on determining the specificity of viral transport through synaptic connections. Analysis of the assembly and intracellular transport of viruses as well as of the role of the brain response to infection were central to this literature. With the growing acceptance that the transport of viruses is circuit-related, attention has shifted to application of the method to define the functional architecture of neural systems. The development of attenuated recombinant viruses that maintain neuroinvasiveness has been instrumental to the generation of increasingly powerful experimental approaches for the functional dissection of neural circuits. These approaches include the use of recombinant viruses that express unique reporters to address issues of axon collateralization in complex circuits, the use of green-fluorescent-protein-expressing recombinants to characterize the electrophysiological properties of projection-specific neurons in live slices of brain, and the exploitation of the Cre recombinase system for conditional replication of virus in phenotypically defined populations of neurons.

Entities:  

Mesh:

Year:  2003        PMID: 14630225     DOI: 10.1016/j.conb.2003.08.001

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  38 in total

1.  Neuron-to-cell spread of pseudorabies virus in a compartmented neuronal culture system.

Authors:  T H Ch'ng; L W Enquist
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture.

Authors:  Jennifer A Schwartz; Elizabeth E Brittle; Ashley E Reynolds; Lynn W Enquist; Saul J Silverstein
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Transcriptome signature of virulent and attenuated pseudorabies virus-infected rodent brain.

Authors:  Christina Paulus; Patricia J Sollars; Gary E Pickard; Lynn W Enquist
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Neural circuits look forward.

Authors:  Sebnem N Tuncdemir; Gord Fishell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-13       Impact factor: 11.205

5.  The neuroinvasive profiles of H129 (herpes simplex virus type 1) recombinants with putative anterograde-only transneuronal spread properties.

Authors:  Gregory J Wojaczynski; Esteban A Engel; Karina E Steren; Lynn W Enquist; J Patrick Card
Journal:  Brain Struct Funct       Date:  2014-03-02       Impact factor: 3.270

6.  The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

Authors:  Piotr Hadaczek; Yoji Yamashita; Hanna Mirek; Laszlo Tamas; Martha C Bohn; Charles Noble; John W Park; Krystof Bankiewicz
Journal:  Mol Ther       Date:  2006-05-02       Impact factor: 11.454

7.  Serotonergic projections from the caudal raphe nuclei to the hypoglossal nucleus in male and female rats.

Authors:  Jessica R Barker; Cathy F Thomas; Mary Behan
Journal:  Respir Physiol Neurobiol       Date:  2008-11-27       Impact factor: 1.931

Review 8.  The alpha-herpesviruses: molecular pathfinders in nervous system circuits.

Authors:  Mats I Ekstrand; L W Enquist; Lisa E Pomeranz
Journal:  Trends Mol Med       Date:  2008-02-14       Impact factor: 11.951

9.  Neurons in the cochlear nuclei controlling the tensor tympani muscle in the rat: a study using pseudorabies virus.

Authors:  I Billig; M S Yeager; A Blikas; Y Raz
Journal:  Brain Res       Date:  2007-04-06       Impact factor: 3.252

10.  In vitro analysis of transneuronal spread of an alphaherpesvirus infection in peripheral nervous system neurons.

Authors:  B Feierbach; M Bisher; J Goodhouse; L W Enquist
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.